Reduce Your Risk With Biologics Testing Solutions

In line with our everyday focus of providing solutions to biologics developers, we are excited to announce that our Biopharmaceutical Services (BPS) division will now be known as Biologics Testing Solutions. Charles River has expanded and strengthened our offerings in biologics testing through the development of new assays, the opening of our viral clearance sites and the addition of a new insourcing/outsourcing program called RightSourceSM.

Placing your tests with Charles River reduces your risk of unexpected results and enhances the visibility you have around your study. You can now consolidate the discovery, safety assessment, CMC and post market support of your biologic into one contract testing organization.

Comprehensive Portfolio
Our portfolio of biologics testing for manufacturing is the most robust in the industry. Spanning the drug development continuum from early research and development through to clinical and post-market support, our offerings include:

• Viral Clearance Studies
• Biologics Testing including biosafety testing and impurity/residual detection
• Cell Banking
• Cell Line and Protein Characterization

Consistency and Reliability

• Dependable Timelines We work with you to meet your deadlines and, if necessary, expedite results so that you are able to make important go/no go decisions.
• Project Manager Support Our project managers ensure the appropriate testing plan is carried out through proactive communication of testing updates and preliminary testing results.
• Appropriate Testing Plans We work with you to determine what is needed to take your biologic to the next development step, no more no less.

Specialty in Biologics Testing

• Scientific Excellence Our scientists come from a diverse background and are familiar with the development and commercialization of biologics, allowing us to translate our experiences into solutions tailored to your unique needs
• Experience At our seven global sites, we perform thousands of assays each month. The results from these tests are used by companies all over the world to advance the development of their biologics.